March 3, 2026

NewAmsterdam Pharma (NAMS) Stock Analysis: Exploring a 46.68% Potential Upside Amidst Strong Buy Ratings

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a Netherlands-based biopharmaceutical firm, is currently capturing investor attention with its significant growth potential and a robust lineup of analyst..

CG Oncology, Inc. (CGON) Stock Analysis: A 39% Potential Upside in the Battle Against Bladder Cancer

CG Oncology, Inc. (NASDAQ: CGON) stands as a formidable player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $4.77 billion,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring the 316.79% Potential Upside

For investors seeking high-growth opportunities in the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) offers an intriguing proposition with its remarkable potential upside. As a clinical-stage..

Ascentage Pharma Group Internat (AAPG): Investor Outlook on a Biotech Innovator with 108% Upside Potential

Ascentage Pharma Group International (AAPG), a pioneering force in the biotechnology industry, is capturing investor attention with its ambitious pipeline of therapies poised to address critical..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Gem with 15.82% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK), a budding entity in the biotechnology landscape, commands attention with its promising pipeline and a robust market cap of $4.44..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a 145% Upside Potential Amidst Strong Analyst Support

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) is capturing investor attention with its ambitious pipeline and potential for significant upside. As a biotechnology company focused on rare and..

Beam Therapeutics Inc. (BEAM): Investor Outlook with 74% Potential Upside in the Biotech Sector

Beam Therapeutics Inc. (NASDAQ: BEAM) is making waves in the biotechnology sector with its precision genetic medicines, targeting serious diseases through innovative therapies. With a market..

Brookdale Senior Living Inc. (BKD): Investor Outlook Highlights 28% Upside Potential

Brookdale Senior Living Inc. (BKD) is a pivotal player in the healthcare sector, specifically within the medical care facilities industry in the United States. With a..

Acadia Healthcare (ACHC) Stock Analysis: A Closer Look at its Challenges and Potential Amidst a -3.10% Upside

Investors interested in the healthcare sector, particularly the niche market of behavioral healthcare services, may find Acadia Healthcare Company, Inc. (NASDAQ: ACHC) a noteworthy candidate. With..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Exploring a 178% Upside Potential

Viking Therapeutics, Inc. (NASDAQ: VKTX) has emerged as a compelling player in the biotechnology sector, capturing the attention of investors with its innovative pipeline and substantial..

PACS Group, Inc. (PACS) Stock Analysis: A Promising 20.63% Upside in the Healthcare Sector

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, is capturing investor attention with its impressive potential upside of 20.63%. Specializing in the operation..

Alvotech (ALVO) Stock Analysis: Exploring a Potential 375% Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based company specializing in the development and manufacture of biosimilar medicines, has caught the attention of investors with its promising growth potential...

Galapagos NV (GLPG): Unpacking the 1,093% Revenue Growth and What It Means for Investors

Investors with an eye on the biotechnology sector might find Galapagos NV (NASDAQ: GLPG) a compelling company to consider, especially given its striking revenue growth of..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Unpacking a 35.24% Upside Potential

Edgewise Therapeutics, Inc. (EWTX), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising 35.24% potential upside. The company’s focus..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Robust Growth Potential with 23% Upside

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Kiniksa Pharmaceuticals International (NASDAQ: KNSA). With a market capitalization of $3.49..

Ardent Health, Inc. (ARDT) Stock Analysis: A 37.83% Potential Upside in Focus for Investors

Ardent Health, Inc. (NYSE: ARDT) stands out in the healthcare sector as a robust player in the medical care facilities industry. With a market capitalization of..

Organon & Co. (OGN) Stock Analysis: Key Insights on Its 25.17% Potential Upside

For investors with a keen interest in the healthcare sector, Organon & Co. (NYSE: OGN) offers a compelling case study. With a market capitalization of $1.87..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: Unpacking a 105% Potential Upside for Growth Investors

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is capturing the attention of growth-oriented investors with its compelling development pipeline and an eye-catching potential upside of 105.26%. The company,..

ICU Medical, Inc. (ICUI) Investor Outlook: A 24% Upside Potential Amid Healthcare Innovation

ICU Medical, Inc. (NASDAQ: ICUI) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the medical instruments and supplies industry. With..

ImmunityBio, Inc. (IBRX) Stock Analysis: A Biotech Powerhouse with 29% Upside Potential

ImmunityBio, Inc. (NASDAQ: IBRX) stands as a formidable player in the biotechnology sector, capturing investor interest with its innovative approach to immunotherapy. With a market cap..

Search

Funds

March 3, 2026

Search

Funds

March 3, 2026

FTSE 100

Funds